InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Ling Karen, Director. Officer active across 4 companies, notably TherapeuticsMD, Inc.. Cumulatively, 17 disclosures have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €82k. History available since 17 August 2021. The latest transaction was disclosed on 26 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Ling Karen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
15,842 shares@ US$15.780.0037% mcap100.0% of flowCommon Shares, No Par ValueSEC:0001860742-26-000078:0
4,000 shares@ US$17.74221.9% of flowCommon Shares, No Par ValueSEC:0001860742-26-000020:0
Canonical exit: 20 May 2026 (T+90)
1,358 shares0Common StockSEC:0001388658-25-000129:0
20,338 shares0Common Shares, No Par ValueSEC:0001127602-25-015803:0
14,696 shares0Common Shares, No Par ValueSEC:0001127602-24-021757:0
1,841 shares0Common StockSEC:0001388658-24-000122:0
2,642 shares0Common Shares, No Par ValueSEC:0001127602-24-009005:0
23,122 shares0Ordinary SharesSEC:0001104659-23-119109:0
1,396 shares0Common StockSEC:0001388658-23-000128:0
3,154 shares@ US$1.28100.0% of flowOrdinary SharesSEC:0001104659-23-076469:0
1,164 shares0Common StockSEC:0001388658-23-000054:0
26,277 shares0Ordinary SharesSEC:0001104659-23-001542:0
1,984 sharesCommon StockSEC:0001209191-22-046965:0
653 shares0Common StockSEC:0001388658-22-000072:0
4,320 shares0Common StockSEC:0001388658-21-000147:0
33,445 shares@ US$0.75100.0% of flowCommon StockSEC:0001387131-21-008750:0
Canonical exit: 15 Nov 2021 (T+90)
96,864 sharesCommon StockSEC:0001387131-21-008433:0
17 of 17 declarations
About Ling Karen
Ling Karen is Administrateur and is linked to iRhythm Technologies, Inc., Bausch & Lomb Corp, Mallinckrodt plc and TherapeuticsMD, Inc. She has 17 filings in total, and across the 17 sampled filings from 2021-08-12 to 2026-05-28, reported purchases total 81621 EUR, reported sales total 0 EUR, with the dominant transaction nature shown as Attribution.
